"After graduation, I was given the opportunity to join Johnson & Johnson's Finance Leadership, Development Program (FLDP) -- a highly competitive program that provides you with two 1-year rotations. Each rotation provides you with varying experiences and allows you to gain exposure to a different function of Finance/Accounting (Supply Chain, Corporate, etc.) as well as a different business segment (i.e. Pharmaceuticals, Medical Devices or Consumer Products). My first role was in Marketing Finance for the Consumer Segment (a very commercial facing role with key business partners in Marketing, Sales & Supply Chain functions). This role was phenomenal and allowed me to apply my financial expertise in a "creative way." I owned forecasted to actualized data for brands such as Neosporin, Band-Aid and Compeed. My current role (2nd rotation) is a Corporate function supporting External Reporting/Investor Relations. My primary responsibilities revolve around Enterprise Sales Reporting for both top internal management (Executive Committee/Board of Directors) and the external investment community (SEC filings, earnings press releases & analyst presentations, etc.). On the IR side, I am responsible for corresponding with JNJ's ~ 20 equity analysts, leveraging their models to track estimates and perform comparative analytics vs. our internal forecasts. In addition to this, I analyze the earnings releases of JNJ's ~30 competitors and summarize each company's performance/changes to financial guidance in a schedule sent directly to Alex Gorsky (CEO) & Dominic Caruso (CFO). In addition to the mentioned responsibilities, I work on many ad-hoc projects for the CFO, Corp. Controller, VP of Investor Relations and other senior executives, which provides significant learning in framing and communicating, as well as understanding issues and concerns regarding our business, macro-economic conditions, regulatory issues, or investor concerns from the perspective of a senior leader."